Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)

Thomas A. Wadden; Ariana M. Chao; Sriram Machineni; Robert Kushner; Jamy Ard; Gitanjali Srivastava; Bruno Halpern; Shuyu Zhang; Jiaxun Chen; Mathijs C. Bunck; Nadia N. Ahmad; Tammy Forrester

doi:10.1038/s41591-024-02883-1

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)

Thomas A. Wadden, Ariana M. Chao, Sriram Machineni, Robert Kushner, Jamy Ard, Gitanjali Srivastava, Bruno Halpern, Shuyu Zhang, Jiaxun Chen, Mathijs C. Bunck, Nadia N. Ahmad, Tammy Forrester

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02597-w, published online 15 October 2023. In the originally published version of this article, the labels in the Fig. 2 key for panels b and f (now shown as “Tirzepatide MTD” and “Placebo” for the inverted blue triangle and white box, respectively) were swapped. This error has been corrected in the HTML and PDF versions of the article.

Original language	English (US)
Journal	Nature Medicine
DOIs	https://doi.org/10.1038/s41591-024-02883-1
State	Accepted/In press - 2024

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41591-024-02883-1

Cite this

Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck, M. C., Ahmad, N. N., & Forrester, T. (Accepted/In press). Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w). Nature Medicine. https://doi.org/10.1038/s41591-024-02883-1

Wadden, TA, Chao, AM, Machineni, S, Kushner, R, Ard, J, Srivastava, G, Halpern, B, Zhang, S, Chen, J, Bunck, MC, Ahmad, NN & Forrester, T 2024, 'Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)', Nature Medicine. https://doi.org/10.1038/s41591-024-02883-1

@article{494cee61578f446da47d05e3d2dde928,

title = "Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02597-w, published online 15 October 2023. In the originally published version of this article, the labels in the Fig. 2 key for panels b and f (now shown as “Tirzepatide MTD” and “Placebo” for the inverted blue triangle and white box, respectively) were swapped. This error has been corrected in the HTML and PDF versions of the article.",

author = "Wadden, {Thomas A.} and Chao, {Ariana M.} and Sriram Machineni and Robert Kushner and Jamy Ard and Gitanjali Srivastava and Bruno Halpern and Shuyu Zhang and Jiaxun Chen and Bunck, {Mathijs C.} and Ahmad, {Nadia N.} and Tammy Forrester",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

doi = "10.1038/s41591-024-02883-1",

language = "English (US)",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Author Correction

T2 - Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)

AU - Wadden, Thomas A.

AU - Chao, Ariana M.

AU - Machineni, Sriram

AU - Kushner, Robert

AU - Ard, Jamy

AU - Srivastava, Gitanjali

AU - Halpern, Bruno

AU - Zhang, Shuyu

AU - Chen, Jiaxun

AU - Bunck, Mathijs C.

AU - Ahmad, Nadia N.

AU - Forrester, Tammy

PY - 2024

Y1 - 2024

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02597-w, published online 15 October 2023. In the originally published version of this article, the labels in the Fig. 2 key for panels b and f (now shown as “Tirzepatide MTD” and “Placebo” for the inverted blue triangle and white box, respectively) were swapped. This error has been corrected in the HTML and PDF versions of the article.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02597-w, published online 15 October 2023. In the originally published version of this article, the labels in the Fig. 2 key for panels b and f (now shown as “Tirzepatide MTD” and “Placebo” for the inverted blue triangle and white box, respectively) were swapped. This error has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85185978453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85185978453&partnerID=8YFLogxK

U2 - 10.1038/s41591-024-02883-1

DO - 10.1038/s41591-024-02883-1

M3 - Comment/debate

AN - SCOPUS:85185978453

SN - 1078-8956

JO - Nature Medicine

JF - Nature Medicine

ER -

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial(Nature Medicine, 10.1038/s41591-023-02597-w)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this